Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/7047
Title: | Technical note: durable resolution of hydrocephalus after ultrasound-guided percutaneous fenestration of giant suprasellar arachnoid cyst in a neonate | Authors: | Stuart, Michael J. Yoon, Joseph McEniery, Jane Jardim, Amelia J. Vonhoff, Craig |
Issue Date: | 2024 | Source: | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2024 (40) 12 p.4279-4282 | Pages: | 4279-4282 | Journal Title: | Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery | Abstract: | Arachnoid cysts are relatively common, but rarely require intervention. While most arachnoid cysts in typical middle or posterior cranial fossa locations are seldom symptomatic, suprasellar cysts may become symptomatic due to the potential for ventricular outflow obstruction and hydrocephalus. Typical standard of care for the treatment of these lesions is endoscopic fenestration with third ventriculostomy, or the placement of ventriculoperitoneal or cystoperitoneal shunts. The surgical and anaesthetic risks of traditional interventions may be higher in the early neonatal period, including leak of cerebrospinal fluid, infection, and premature failure of ventriculostomy or shunts. This note describes a novel bedside ultrasound-guided technique to percutaneously fenestrate large suprasellar arachnoid cysts under local anaesthesia. The technique involves insertion of a 25-g spinal needle until contact with the membrane of the arachnoid cyst medially, followed by a lateral sweeping to widely incise/fenestrate the lesion into the ventricular space under continuous ultrasound visualisation. This note describes an example case which demonstrates durable radiological and clinical improvement after 2 years of follow-up. This may represent a management option to temporise, or perhaps definitively manage suprasellar arachnoid cysts in the neonatal period.; Competing Interests: Declarations. Ethical approval and consent to participate: The use of the example case to illustrate this technique is endorsed by the Children’s Health Queensland human research ethics committee, and with the informed written consent of the patient’s family. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose. (© 2024. Crown.) | DOI: | 10.1007/s00381-024-06560-z | Resources: | https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,athens&db=mdc&AN=39138665&site=ehost-live |
Appears in Sites: | Children's Health Queensland Publications Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.